How to Buy Alimera Sciences Stock
Alimera Sciences Inc
Alimera Sciences, Inc. , a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally.
Alimera Sciences stock last closed at $3.63, up 1.11% from the previous day, and has increased 75.45% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.86 percentage points. Alimera Sciences stock is currently +132.69% from its 52-week low of $1.56, and -17.12% from its 52-week high of $4.38.
As of Apr 24, 2024, there are 52.35M shares of ALIM outstanding. The market value of ALIM is $190.05M. In the past 24 hours, 7722 ALIM shares were traded.
How to Buy Alimera Sciences Stock
Wondering how to invest in Alimera Sciences stock? Here's how.
- Choose where to buy Alimera Sciences stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Alimera Sciences stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your payment method and add your information.
- Evaluate Alimera Sciences stock: The Alimera Sciences ticker symbol is ALIM. Is Alimera Sciences stock a good investment? Should you buy shares of ALIM? How do ALIM's underlying business fundamentals look? Do top analysts think Alimera Sciences is a good buy? Why has ALIM's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if ALIM is a good stock to buy).
- Execute your ALIM buy order: Decide if you will purchase ALIM shares at the current market price or use a limit order to purchase ALIM shares at a specific price.
- Get the latest scoop on your ALIM investment: Create a watchlist to get live updates on your position in Alimera Sciences shares.
Step 1: Choose where to buy Alimera Sciences stock
You will need an online brokerage account to access the NASDAQ market and buy ALIM shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal details so you can buy ALIM stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new trading account.
- Send your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have finished signing up on one of the most highly reviewed stock apps, you can securely and quickly fund your account:
Check out the tutorial below to see the process of depositing money into your new brokerage account.
Step 4: Evaluate Alimera Sciences stock
After you have selected the best place to buy Alimera Sciences stock, it's important to analyze their stock prior to buying, so you truly understand the risk as well as the upside.
Alimera Sciences Numbers
Alimera Sciences Overview
WallStreetZen was designed to help average investors do better fundamental analysis.
You can see all of the due diligence checks on ALIM's stock page.
Is ALIM stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ALIM's true value.
Using relative valuations methods:
- ALIM may be overvalued based on its P/B ratio of 4.12x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.06x
You can do more valuation analysis on ALIM's stock here.
ALIM Financial Overview
Signs that ALIM is financially healthy:
- Total ALIM debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the ALIM balance sheet.
Signs that ALIM is not financially healthy:
- ALIM profit margin has gone up by 0.07 percentage points in the past year, but the company is still unprofitable.
- ALIM has cash burn of 14521000. It does not have enough cash and short-term investments to cover this.
- There are more long-term liabilities than short-term assets on the ALIM balance sheet.
- ALIM has a relatively high debt to equity ratio of 2.33.
- ALIM has $12.09M in cash and short term investments. This is not enough to cover its annual cash burn of $14.52M.
Do analysts think it's a good time to buy ALIM stock
Out of 2 Equities analysts who give recommendations on ALIM, the consensus analyst rating on ALIM is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Alimera Sciences stock forecast page.
ALIM Technicals
How is ALIM performing as a company?
Last year, ALIM revenue was $80.75M. Over the past 5 year, ALIM's revenue has grown by 11.62% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.89%.
You can research ALIM's earnings and revenue performance here.
Latest Insiders Trades at ALIM
In the past year, executives and large shareholders at ALIM have bought more shares than they have sold.
Philip Ashman, President of Intl Operations of ALIM, was the latest ALIM insider to sell. They sold $46,354.49 worth of ALIM shares on Mar 26, 2024.
Learn more about who owns ALIM stock here.
Does ALIM provide a stable income stream?
No, Alimera Sciences doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your ALIM buy order
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price limit, place a limit order.
Press the Open Trade button and your broker will execute your order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your ALIM investment
Now that you own some shares in ALIM, you'll want to keep up with your new stock purchase.
Start a watchlist to track the most important metrics related to your ALIM stock.
ALIM Feed
How to Buy Stock in Alimera Sciences
To reiterate, here are the 6 steps you need to take to buy Alimera Sciences stock right now:
- Choose where to buy Alimera Sciences stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Evaluate Alimera Sciences stock
- Execute your ALIM buy order
- Get the latest scoop on your ALIM investment
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Alimera Sciences, click below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.